Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |
APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition? |
Children’s Hospital of Philadelphia / Abby Green, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine / Mireya Paulina Velasquez, MD |
Young Investigator Grants |
2014 |
Texas |
Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients |
Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Targeting the Accomplices of MYC in MYC-driven Medulloblastoma |
Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D. |
Innovation Grants |
2014 |
California |
Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia |
The Johns Hopkins University School of Medicine / Linda Resar, M.D. |
Innovation Grants |
2014 |
Maryland |
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma |
Dana-Farber Cancer Institute / Thomas Look, M.D. |
Innovation Grants |
2014 |
Massachusetts |
Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering |
Massachusetts General Hospital / Hanno Hock, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida / Steven Ghivizzani, Ph.D. |
Innovation Grants |
2014 |
Florida |